Mehalick David
Coeptis Therapeutics Holdings, Inc. · CEO and President
Mehalick David is listed in public filings as director, 10 percent owner, officer: CEO and President. This Mehalick David insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Coeptis Therapeutics Holdings, Inc. (COEPW). Investors use Mehalick David's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.3M330.2k shares | Grant / ExerciseFeb 11, 2026 | $1.0M148.9k shares | $7.05 | -- | |
| --330.2k shares | Grant / ExerciseFeb 11, 2026 | Disclosure amount unavailable51.3k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.1M200.1k shares | Grant / ExerciseMar 4, 2025 | $304.9K28.9k shares | $10.56 | -- |